| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664004A1 Method for the production of 4-(4-aminophenyl)-3-morpholinon |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/06/2006 | US7056916 Using a 1,4- benzoxazin-3-one compound |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | CA2362632C R-substituted-2- or 3-aminomethyl-4-amino-3,4-dihydro-2h-1,4-benzoxazines as intermediates for producing analgesic agents |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006029079A3 Synthesis of a benzoxazinone |
| 06/01/2006 | US20060116368 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1546123B1 Benzyl morpholine derivatives |
| 05/30/2006 | US7053138 For thermoplastic, thermosetting resin; using phosphinic compound |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053085 EP4 receptor agonist, compositions and methods thereof |
| 05/30/2006 | CA2187969C A template for solution phase synthesis of combinatorial libraries |
| 05/25/2006 | US20060111352 Acetylenic compounds useful in treating inflammatory disorders |
| 05/25/2006 | US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049271 Herbicides, acaricides, nematicides and insecticides |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106213 New Medicaments for the Treatment of Chronic Obstructive Pulmonary Disease |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106017 Novel o-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 05/18/2006 | US20060106012 Benzoxazine and quinoxaline derivatives and uses thereof |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105412 Phthalein or 9-(o-carboxyphenyl)xanthone compound to which is attached a phenylsulfonyloxy group in which the benzene ring is substituted with an alkyl halide group, a nitro group or a cyano electron-withdrawing group; when the sulfonate bond is cleaved, fluorescein or a derivative is formed |
| 05/18/2006 | US20060105410 Sulfonate compound and fluorescent probe using the same |
| 05/17/2006 | EP1481012B1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization |
| 05/16/2006 | US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/16/2006 | CA2195724C Process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer |
| 05/11/2006 | WO2006049038A1 Process for producing optically active 3-(hydroxymethyl)morpholine derivative |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100106 Phenyl-substituted 2-enamino-ketonitriles |
| 05/10/2006 | EP1654240A1 Method for production of n-aryl morpholinones |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1255389C Morpholol with medicinal activity |
| 05/09/2006 | US7041821 substituted 3-hydroxy-6-oxo-9-phenyl anthracene, acridine, xanthene, or thioxanthene zinc chelating compounds; fluorescent labels for recombinant fusion proteins; nontoxic alternative to nickel based labeling systems; nonreducing environments, cell surfaces |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/04/2006 | WO2006047503A2 Inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047479A2 C-fms kinase inhibitors |
| 05/04/2006 | WO2006045505A1 Mif-inhibitors |
| 05/04/2006 | US20060094874 Novel substituted aryl alkenoic acid heterocyclic amides |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | CA2581981A1 Mif-inhibitors |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | CN1768149A Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 05/03/2006 | CN1768046A Amine-substituted diphenyldiphosphines and its application in asymmetric synthetic metal complex |
| 05/03/2006 | CN1765900A Spiro oxazone derivative containing naphthalimide unit |
| 05/02/2006 | US7038044 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
| 04/27/2006 | WO2005054871A3 Analysis of mass spectral data in the quiet zones |
| 04/27/2006 | US20060089497 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | DE102004050283A1 4-Aminophenyl-morpholinon-Derivate und deren Herstellung 4-aminophenyl-morpholinone derivatives and their preparation |
| 04/26/2006 | EP1650200A1 Sulfonate compound and fluorescent probe using the same |
| 04/26/2006 | EP1648921A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 04/26/2006 | CN1764659A Prostaglandin analogs as EP4 receptor antagonists |
| 04/26/2006 | CN1763019A 1,4-benzoxazolezin-3-ketone compound microwave synthesis method |
| 04/26/2006 | CN1762965A A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
| 04/25/2006 | US7034110 Method of identifying chemical compounds having selected properties for a particular application |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | CA2167291C Substituted 2-phenylpyridines with herbicidal action |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006040643A2 Polymorphic forms of efavirenz and processes for their preparation |
| 04/20/2006 | WO2005113524A8 Fluorescent method and compounds to monitor protein-lipid binding |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/19/2006 | CN1252038C New derivatives of substituted anilines with herbicidal activity |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030111 drugs such as 4-chloro-benzoic acid p-tolyl ester, used to control or suppress the onset of mitosis until DNA replication and repair are complete; prophylaxis of proliferative disorders |
| 04/13/2006 | WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 04/13/2006 | WO2006037481A1 Benzoxazine and quinoxaline derivatives and uses |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | CA2581921A1 Benzoxazine and quinoxaline derivatives and uses |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/06/2006 | WO2005051869A3 Carbon-carbon cross coupling catalyzed by transition metals on solid supports |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074086 N-(4-{3'-[(3-ethylureido)-methyl]-2-hydroxybiphenyl-4-yl}-4-methylpentyl)-2,2-dimethylpropionamide; pain, gastrointestinal , genitourinary disorders, inflammation, glaucoma, autoimmune diseases, ischemic conditions, and neurodegenerative diseases, for cardioprotection against ischemic |